AAP
KMTS

Arax Advisory Partners’s Kestra Medical Technologies KMTS Stock Holding History

Arax Advisory Partners’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100 Buy
+38
New +$896 ﹤0.01% 3614
2025
Q4 		– Sell
-117
Closed -$2.78K – 4628
2025
Q3 		$2.78K Buy
+117
New +$2.09K ﹤0.01% 3030

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arax Advisory Partners's KMTS Position: Q1 2026 in Review

Arax Advisory Partners opened a new position in Kestra Medical Technologies (KMTS) in Q1 2026: 38 shares worth $100. The stake represents ﹤0.01% of the portfolio and ranks #3614 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in KMTS as recently as Q3 2025.

Arax Advisory Partners first reported a position in KMTS in Q3 2025 and has held it in 2 quarters since. The position peaked at $2.78K in Q3 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Arax Advisory Partners held 38 shares of Kestra Medical Technologies worth $100 as of Q1 2026.
  • Kestra Medical Technologies was a new Arax Advisory Partners position in Q1 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3614 holding.
  • Arax Advisory Partners first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's Kestra Medical Technologies position peaked at $2.78K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.